Rickettsiosis

disease
On this page

Also known as infection, Rickettsiainfections, RickettsiaRickettsia caused disease or disorderRickettsia disease or disorderRickettsia infectionRickettsia infectious diseaseRickettsiae diseaseRickettsial diseaseRickettsial infectious diseaseRickettsial infectious disorder

Summary

Rickettsiosis (MONDO:0006956) is a disease and 7 clinical trials. A subtype of bacterial infectious disease — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

At a glance

  • Clinical trials: 7

Clinical features

No curated clinical features (Orphanet) for this disease.

Identifiers

Disease identifiers

FieldValue
Canonical nameRickettsiosis
Mondo IDMONDO:0006956
EFOEFO:1001162
MeSHD012282
Orphanet102021
ICD-10-CMA75-A79
NCITC34991
SNOMED CT37246009
UMLSC0035585
MedGen20584
GARD0019827
MedDRA10061495
Is cancer (heuristic)no

Also known as: infection, Rickettsia · infections, Rickettsia · Rickettsia caused disease or disorder · Rickettsia disease or disorder · Rickettsia infection · Rickettsia infectious disease · Rickettsiae disease · Rickettsial disease · Rickettsial infectious disease · Rickettsial infectious disorder · Rickettsiosis

Disease family

This is a subtype of bacterial infectious disease. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.

Classification path: disease › human disease › disease by etiologic mechanism › disease of primarily extrinsic mechanism › infectious diseasebacterial infectious diseaseRickettsiosis

Related subtypes (51): primary bacterial infectious disease, commensal bacterial infectious disease, opportunistic bacterial infectious disease, chorioamnionitis, Clostridium difficile colitis, bacterial gastritis, bacterial arthritis, bacterial pneumonia, Whipple disease, Aeromonas hydrophila infectious disease, Pectobacterium carotovorum infection, Pseudomonas infection, septic peritonitis, bacterial infectious disease with sepsis, empyema, bacterial urinary tract infection, bacterial sexually transmitted disease, meningococcal infection, pasteurellosis, peritonsillar abscess, pneumonic pasteurellosis, tracheitis, Actinobacillus infectious disease, bacterial conjunctivitis, bacterial endocarditis, bacterial meningitis, Bifidobacteriales infectious disease, haemophilus infectious disease, Proteus infectious disease, pulpitis, rat-bite fever, vibrio infectious disease, Yersinia infectious disease, bacterial myositis, noma, idiopathic severe pneumococcemia, necrotizing soft tissue infection, mycobacterial infectious disease, escherichia coli infection, gram-negative bacterial infections, gram-positive bacterial infections, spirochaetales infections, skin disease caused by bacterial infection, staphylococcal infection, anaerobic bacteria infectious disease, Klebsiella infectious disease, fournier gangrene, botryomycosis, bacterial hemorrhagic fever, Mycoplasmoides infection, Enterococcus infectious disease

Subtypes (3): tick-borne relapsing fever, Anaplasmataceae infectious disease, Rickettsiaceae infectious disease

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 7.

Phase distribution (across all retrieved trials)

PhaseTrials
Not specified7

Top trials by phase / activity

NCTPhaseStatusTitle
NCT06162975Not specifiedRECRUITINGThe Surveillance Clinical Study of Rickettsiosis
NCT06859619Not specifiedNOT_YET_RECRUITINGSerological Measurement of Montpellier Professionals’ Contacts with Infectious Agents Responsible for Animal-borne Diseases
NCT07307651Not specifiedNOT_YET_RECRUITINGImplementation of an RT-PCR Assay for the Diagnosis of Rickettsia Spp. Infection
NCT00326534Not specifiedCOMPLETEDRickettsial Genesis to Sarcoidosis in Denmark
NCT01766830Not specifiedCOMPLETEDRapid Diagnostic Tests and Clinical/Laboratory Predictors of Tropical Diseases In Patients With Persistent Fever in Cambodia, Nepal, Democratic Republic of the Congo and Sudan (NIDIAG-Fever)
NCT02339259Not specifiedCOMPLETEDCauses of Fever in Bangladeshi Patients
NCT05458245Not specifiedUNKNOWNTIBOLA : Multicenter Descriptive Study in Eastern France

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.